drugset

drugset / Trial / NCT00000302

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

NCT00000302 ↗

Phase 3 Completed National Institute on Drug Abuse (NIDA)

Double-blindTreatment

Summary

The purpose of this study is to compare liquid and tablet buprenorphine formulations.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Buprenorphine	Other / unclassified	—	—

Indications